BORTOLOTTI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 2.777
EU - Europa 2.265
AS - Asia 1.019
AF - Africa 178
SA - Sud America 9
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.252
Nazione #
US - Stati Uniti d'America 2.760
IT - Italia 677
GB - Regno Unito 494
CN - Cina 427
DE - Germania 251
SE - Svezia 247
SG - Singapore 214
VN - Vietnam 193
UA - Ucraina 138
IN - India 126
IE - Irlanda 109
CI - Costa d'Avorio 94
FR - Francia 81
RU - Federazione Russa 78
BG - Bulgaria 49
EE - Estonia 42
ZA - Sudafrica 37
FI - Finlandia 28
JO - Giordania 26
BE - Belgio 18
CA - Canada 14
NG - Nigeria 12
GR - Grecia 11
TG - Togo 11
LY - Libia 10
SC - Seychelles 9
CH - Svizzera 8
CL - Cile 7
ES - Italia 7
IR - Iran 6
JP - Giappone 6
RO - Romania 6
HU - Ungheria 5
NL - Olanda 4
DZ - Algeria 3
KR - Corea 3
PH - Filippine 3
PL - Polonia 3
BD - Bangladesh 2
GU - Guam 2
HR - Croazia 2
ID - Indonesia 2
IQ - Iraq 2
MX - Messico 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AU - Australia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
HK - Hong Kong 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.252
Città #
Southend 434
Fairfield 345
Chandler 290
Bologna 267
Ashburn 215
Singapore 192
Woodbridge 178
Wilmington 159
Houston 147
Dong Ket 140
Seattle 137
Princeton 126
Ann Arbor 121
Cambridge 109
Dublin 109
Abidjan 94
Jacksonville 94
Nanjing 54
Westminster 52
Turin 51
Sofia 49
Berlin 47
Padova 45
Beijing 40
Jinan 37
Santa Clara 34
Saint Petersburg 31
Amman 26
Hebei 26
Redmond 26
Nanchang 24
Guangzhou 22
Medford 22
Mülheim 22
Redwood City 22
San Diego 22
Shenyang 21
Lappeenranta 20
Boardman 19
Milan 19
Brussels 18
Des Moines 18
Changsha 16
Dearborn 14
Los Angeles 14
Nashville 13
Shanghai 13
Tianjin 13
Zhengzhou 13
Abeokuta 12
Hyderabad 12
Lomé 11
Nonantola 10
Verona 10
Forlì 9
Norwalk 9
Sasso Marconi 9
Washington 9
Hangzhou 8
Helsinki 8
Mahé 8
Jiaxing 7
Lanzhou 7
London 7
Reggio Emilia 7
Rome 7
Bühl 6
Florence 6
Phoenix 6
Taiyuan 6
Taizhou 6
Toronto 6
Bern 5
Chicago 5
Falls Church 5
Ferrara 5
Haikou 5
Kunming 5
Modena 5
Suzhou 5
Torino 5
Xi'an 5
Balassagyarmat 4
Campogalliano 4
Enna 4
Frankfurt am Main 4
Frattamaggiore 4
Mondolfo 4
Ningbo 4
Olalla 4
Paris 4
Ravenna 4
San Venanzo 4
Solbiate Olona 4
Spilamberto 4
Tokyo 4
Valladolid 4
Wuhan 4
Buffalo 3
Calderara Di Reno 3
Totale 4.326
Nome #
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 159
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) 152
RIP activity in basic protein fractions of tissue extracts from Fragaria x ananassa 151
High in vitro anti-tumor efficacy of dimeric rituximab/saporin-S6 immunotoxin 147
Ricin: An ancient story for a timeless plant toxin 146
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview 143
Survival and death of intestinal cells infected by Chlamydia trachomatis 139
Rituximab and other new anti-CD20 mAbs for non-Hodgkin’s lymphoma treatment. 136
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity 136
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. 128
Bouganin, an attractive weapon for immunotoxins 121
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells 120
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms 118
Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla. 118
Hyperuricaemia, xanthine oxidoreductase and ribosome-inactivating proteins from plants: The contributions of fiorenzo stirpe to frontline research 118
Saporin-S6: a useful tool in cancer therapy. 116
Ribosome-inactivating proteins from plants: A historical overview 116
Anti-tumor activity of Epratuzumab/saporin-S6. 115
Momordica charantia, a nutraceutical approach for inflammatory related diseases 113
Two different in vitro tests confirm the blocking activity of d-galactose lectins on the adhesion of Escherichia coli F4 to pig brush border receptors 111
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia 111
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling 111
Cell interaction of the type 1 RIP Saporin 110
Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells 110
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy 110
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase 110
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine 109
The role of xanthine oxidoreductase and uric acid in metabolic syndrome 108
Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms 106
Protein synthesis inhibition activity by strawberry tissue protein extracts during plant life cycle and under biotic and abiotic stresses 105
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6 104
Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo). 103
Xanthine Oxidoreductase in Drug Metabolism: Beyond A Role as a Detoxifying Enzyme 103
Endocitosi e traffico intracellulare della Saporina-S6 101
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives 100
Programmed death induced by saporin as compared to ricin in lymphoma cells. 99
Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress 93
Morte cellulare programmataindotta dalle RIP ricina e saporina in cellule linfomatose. 92
Xanthine oxidoreductase in cancer: more than a differentiation marker 92
mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment. 91
Primi studi sull'attività Rip in fragola. 90
Intracellular fate of saporin-S6, a putative drug for anti-cancer therapy 88
Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose 84
Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii 84
null 82
Saporin induces multiple death pathways in lymphoma cells with different intensity, timing as compared to ricin. 82
Insights into penicillin-induced Chlamydia trachomatis persistence 81
Antibody conjugates for sarcoma therapy: How far along are we? 81
Research of new ribosome-inactivating proteins from adenina genus (Passifloraceae); characterization of highly toxic type 2 RIPs from Adenia lanceolata and Adenia stenodactyla. 79
hLL2/saporin: un’immunotossina anti-CD22 con potente attività antitumorale. 73
L’immunotossina ATG/ saporina-S6 per l’eliminazione specifica di linfociti T attivati. 68
null 67
Xanthine oxidoreductase: One enzyme for multiple physiological tasks 67
Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin 58
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? 56
Transcriptional network inference and master regulator analysis of the response to ribosome-inactivating proteins in leukemia cells 55
Pro-aging effects of xanthine oxidoreductase products 55
Sequence, structure, and binding site analysis of kirkiin in comparison with ricin and other type 2 rips 55
Toxin and Immunotoxin Based Therapeutic Approaches 55
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy 54
In vitro evaluation of type II Ribosome-Inactivating Proteins (RIPs) for experimental chemoablation of muscle cells in strabismus and eye-movement disorders. 54
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents 50
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama 44
Toxic Plant Proteins as Experimental Drugs for Human Pathologies 39
Toxin and Immunotoxin Based Therapeutic Approaches 37
The fundamental contribution of prof. Stirpe (and his research group) to the broadening of the scientific perspective on xanthine oxidoreductase 36
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? 35
Gender Influence on XOR Activities and Related Pathologies: A Narrative Review 24
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties 22
Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects 16
Xanthine Oxidoreductase Activities 15
Novel Strategies to Improve Rituximab Efficacy in Non-Hodgkin's Lymphomas 11
Totale 6.468
Categoria #
all - tutte 17.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.275 0 0 92 82 139 133 158 196 175 118 60 122
2020/2021942 167 46 33 46 31 56 14 58 117 47 70 257
2021/20221.119 69 61 63 64 88 73 25 84 56 42 271 223
2022/20231.301 151 119 65 145 89 97 48 61 295 56 135 40
2023/2024535 21 62 52 50 39 90 41 41 34 47 26 32
2024/2025496 101 221 174 0 0 0 0 0 0 0 0 0
Totale 6.468